Providers, advocacy groups and some policymakers are pressing for stronger enforcement of mental health parity laws. But congressional Republicans and Democrats disagree about giving the federal government more enforcement power.
Samantha Huntley had been struggling with heroin addiction for several years. After a month of residential treatment, Huntley and her counselor called her mother to say the family's insurer, UnitedHealthcare, would not extend inpatient coverage.
The FDA claimed 39 drug companies may be blocking generic-drug makers from obtaining samples of their branded products to hinder generic competition.
Kansas' data are too poorly documented to determine whether the state's privatized Medicaid plan is working, according to legislative auditors.
A small number of hospitals and health systems are turning to the courts to challenge Anthem's new policies restricting outpatient imaging and emergency department coverage. Attorneys and industry experts disagree on the cases' merits.
Illinois' governor has cut off Blue Cross & Blue Shield of Illinois from enrolling patients in the state's revamped Medicaid managed-care program, a blow to the dominant insurer.
A doctor, a patient recruiter and four pharmacists in metro Detroit have been indicted on charges ranging from the unlawful overprescribing of opioids to healthcare fraud.
The FDA's approval process for medical devices has been criticized for years for failing to catch problems with defective implants.
U.S. health officials are placing new restrictions on a permanent contraceptive implant that has been subject to reports of painful complications from thousands of women. But the metal implant called Essure will remain on the market.
The California attorney general's allegations that Sutter Health inflates healthcare prices could guide other states that aim to break up highly concentrated markets.
Omni Healthcare is suing the wholesale drug distributor McKesson on behalf of the federal government and 30 states for allegedly repackaging cancer drugs from single-use vials, leading to fraudulent payments and serious infections.
California's attorney general sued Sutter Health for alleged anticompetitive behavior, claiming it overcharged patients and forced insurers into "all or nothing" contracts that hindered low-cost health plan options.